2007
DOI: 10.1016/j.neulet.2007.04.037
|View full text |Cite
|
Sign up to set email alerts
|

SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells

Abstract: Secreted protein acidic and rich in cysteine (SPARC) is highly expressed in human gliomas and promotes glioma invasion. We have shown by cDNA array analysis that SPARC upregulates membrane type 1-matrix metalloproteinase (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) transcripts. To confirm these findings at the protein level and determine whether SPARC expression correlates with increased MMP activity, we used Western blot to assess the levels of MT1-MMP, and gelatin zymography to assess MMP-2 levels and ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
57
0

Year Published

2008
2008
2018
2018

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 86 publications
(64 citation statements)
references
References 28 publications
6
57
0
Order By: Relevance
“…Increased SPARC expression correlates with glioma invasion in vitro (32,33) and in vivo (33)(34)(35). This is accomplished by up-regulation and activation of MMP-2, and a possible mechanism involved in increased SPARC-dependent ECM degradation via MMP may involve galectin-3 (36). However, the effects of SPARC are complex, and the ability of SPARC to promote invasion depends on the level of its secretion and to the local tumor environment (35).…”
Section: Discussionmentioning
confidence: 99%
“…Increased SPARC expression correlates with glioma invasion in vitro (32,33) and in vivo (33)(34)(35). This is accomplished by up-regulation and activation of MMP-2, and a possible mechanism involved in increased SPARC-dependent ECM degradation via MMP may involve galectin-3 (36). However, the effects of SPARC are complex, and the ability of SPARC to promote invasion depends on the level of its secretion and to the local tumor environment (35).…”
Section: Discussionmentioning
confidence: 99%
“…Different tenascin-R peptide fragments can either inhibit or promote microglial migration (Liao et al, 2005). SPARC can similarly be cleaved by proteases and MMPs to yield peptides with distinct functions (Lane et al, 1994;Iruela-Arispe et al, 1995;Sasaki et al, 1997), and can also regulate protease expression and activation (Brekken and Sage, 2000;McClung et al, 2007). Since many proteases are up-regulated after injury by microglia and other cells (Yong, 2005;del Zoppo et al, 2007), it is possible that cleavage of SPARC might facilitate the rapid process motility and chemotaxis of activated microglia (Davalos et al, 2005;Nimmerjahn et al, 2005;Kurpius et al, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…These may explain the paradoxical situation that both low and high levels of SPARC can promote more aggressive invasion than intermediate levels (8). Although the molecular mechanism of SPARC on glioma invasion remains unclear, SPARC has been reported to activate membrane type 1-matrix metalloproteinase (MMP) and MMP-2 (29). SPARC siRNA reduced the activation of phosphorylation of AKT, focal adhesion kinase, and integrinlinked kinase (28,30).…”
mentioning
confidence: 99%